Connection

Giuseppe Curigliano to Prognosis

Back to Details
This is a "connection" page, showing publications Giuseppe Curigliano has written about Prognosis.
Giuseppe Curigliano
Connection Strength
0.139
Prognosis
  1. The evolving landscape of 'next-generation' immune checkpoint inhibitors: A review. Eur J Cancer. 2019 08; 117:14-31.
    View in: PubMed
    Score: 0.037
  2. Homologous recombination deficiency in triple negative breast cancer. Breast. 2019 Jun; 45:15-21.
    View in: PubMed
    Score: 0.036
  3. Breast cancer mortality in European Union: An outlook of good news and bad news in a two-speed Europe! Breast. 2017 Dec; 36:86-88.
    View in: PubMed
    Score: 0.032
  4. Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies. Eur J Cancer. 2020 11; 139:43-50.
    View in: PubMed
    Score: 0.010
  5. Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2-positive breast cancer. Eur J Cancer. 2019 10; 120:1-9.
    View in: PubMed
    Score: 0.009
  6. Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice. Biochim Biophys Acta Rev Cancer. 2017 Dec; 1868(2):527-537.
    View in: PubMed
    Score: 0.008
  7. Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer. Acta Oncol. 2013 Nov; 52(8):1649-56.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.